Table 3.
Multivariate logistical regression analysis on the association between negative scans and BRAFV600E-like and RAS-like tumors
| Model 1b | ||||
|---|---|---|---|---|
| BVL tumors (n = 26) | RL tumors (n = 7) | |||
| Odds ratio (95% CI) | P | Odds ratio (95% CI) | P | |
| Univariate analysis | 11.4 (1.94-67.3) | .007 | 0.046 (0.004-0.479) | .01 |
| Multivariate analysisa | 19.1 (0.891-410) | .06 | 0.056 (0.001-1.92) | .11 |
| Model 2 c | ||||
| BVL tumors (n = 40) | RL tumors (n = 28) | |||
| Odds ratio (95% CI) | P | Odds ratio (95% CI) | P | |
| Univariate analysis | 12.1 (3.76-39.2) | < .001 | 0.074 (0.022-0.259) | < .001 |
| Multivariate analysisa | 19.8 (2.72-144) | .003 | 0.048 (0.006-0.344) | .004 |
Abbreviations: BVL, BRAFV600E like; RL, RAS like.
a Adjusted for age, sex, race, type of preparation for RAI, presence of bone metastasis, and RAI dose.
b Model 1: classification of BVL and RL tumors according to mutational data.
c Model 2: classification of BVL and RL tumors according to available mutational data combined with histology data.